BRPI0415280A - methods for treating vasomotor symptoms - Google Patents

methods for treating vasomotor symptoms

Info

Publication number
BRPI0415280A
BRPI0415280A BRPI0415280-8A BRPI0415280A BRPI0415280A BR PI0415280 A BRPI0415280 A BR PI0415280A BR PI0415280 A BRPI0415280 A BR PI0415280A BR PI0415280 A BRPI0415280 A BR PI0415280A
Authority
BR
Brazil
Prior art keywords
methods
vasomotor symptoms
combination
selective
receptor antagonists
Prior art date
Application number
BRPI0415280-8A
Other languages
Portuguese (pt)
Inventor
Darleen Coleman Deecher
Chad Edward Beyer
Lisa Leventhal
Original Assignee
Wyeth Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US10/685,812 external-priority patent/US20040152710A1/en
Priority claimed from US10/962,897 external-priority patent/US20050130987A1/en
Application filed by Wyeth Corp filed Critical Wyeth Corp
Priority claimed from PCT/US2004/033754 external-priority patent/WO2005037260A2/en
Publication of BRPI0415280A publication Critical patent/BRPI0415280A/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

"MéTODOS PARA O TRATAMENTO DE SINTOMAS VASOMOTORES". A presente invenção se refere a antagonistas seletivos do receptor adrenérgiCO<244>~ 2B~ isolados, dos antagonistas seletivos do receptor adrenérgico<244>~ 2B~ em combinação com inibidores da reabsorção da norepinefrina (NRI) (como um único composto ou como uma combinação de dois ou mais compostos), ou de antagonistas seletivos do receptor adrenérgico<244>~ 2B~ em combinação com inibidores duplos de reabsorção da norepinefrina/inibidor da reabsorção da serotonina (NRI/SRI) (como um único composto ou como uma combinação de dois ou mais compostos), e a métodos para o uso dos mesmos para o tratamento de sintomas vasomotores."METHODS FOR TREATMENT OF VASOMOTOR SYMPTOMS". The present invention relates to selective β2B2-adrenergic receptor antagonists isolated from selective β2B2-adrenergic receptor antagonists in combination with norepinephrine reuptake inhibitors (NRI) (as a single compound or as a combination of two or more compounds), or selective β2B adrenergic receptor antagonists in combination with dual norepinephrine reuptake inhibitor / serotonin reuptake inhibitor (NRI / SRI) (as a single compound or as a combination two or more compounds), and methods for using them to treat vasomotor symptoms.

BRPI0415280-8A 2003-10-14 2004-10-13 methods for treating vasomotor symptoms BRPI0415280A (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US51089703P 2003-10-14 2003-10-14
US10/685,812 US20040152710A1 (en) 2002-10-15 2003-10-14 Use of norepinephrine reuptake modulators for preventing and treating vasomotor symptoms
PCT/US2003/032759 WO2004035058A1 (en) 2002-10-15 2003-10-15 Use of norepinephrine reuptake modulators for preventing and treating vasomotor symptoms
US10/962,897 US20050130987A1 (en) 2003-10-14 2004-10-12 Methods of treating vasomotor symptoms
PCT/US2004/033754 WO2005037260A2 (en) 2003-10-14 2004-10-13 Use of adrenergic alphaze antagonists for the treatment of vasomotor symptoms

Publications (1)

Publication Number Publication Date
BRPI0415280A true BRPI0415280A (en) 2006-12-19

Family

ID=36566007

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0415280-8A BRPI0415280A (en) 2003-10-14 2004-10-13 methods for treating vasomotor symptoms

Country Status (4)

Country Link
JP (1) JP2007515395A (en)
BR (1) BRPI0415280A (en)
CA (1) CA2539757A1 (en)
TW (1) TW200526227A (en)

Also Published As

Publication number Publication date
TW200526227A (en) 2005-08-16
JP2007515395A (en) 2007-06-14
CA2539757A1 (en) 2005-04-28

Similar Documents

Publication Publication Date Title
BRPI0716069A2 (en) compound, pharmaceutical composition, and method for treating a disorder
BRPI0510142A (en) compounds, compositions and methods for stabilizing transthyretin and inhibiting defective duplication of transthyretin
NO20084435L (en) C-MET protein kinase inhibitors
NO20063620L (en) Arylaniline derivatives as beta2 adrenergic receptor agonists
NO20083057L (en) Sulfonyl substituted 1H-indoles as ligands for 5-hydroxytryptamine receptors
EA200100748A1 (en) MONOAMINE RETURN INHIBITORS FOR THE TREATMENT OF CNS DISORDERS
EA201000603A1 (en) APPLICATION OF ANTIBODIES TO TRKB FOR THE TREATMENT OF RESPIRATORY DISTURBANCES
NO20083204L (en) Combination of an H3 antagonist / inverse agonist and an appetite suppressant
TW200720268A (en) 1h-benzimidazole-4-carboxamides substituted with a quaternary carbon at the 2-position are potent PARP inhibitors
NO20056134L (en) Combination of an NMDA receptor antagonist and a selective serotonin reuptake inhibitor for the treatment of depression and other mood disorders
BRPI0607532A2 (en) dihydrobenzofuranyl alkanamine derivatives as 5ht2c agonists
CY1109763T1 (en) MATERIALS AND METHOD FOR TREATMENT OF CELLULAR DISORDERS
TW200736229A (en) Substituted 1H-benzimidazole-4-carboxamides are potent PARP inhibitors
CL2008000202A1 (en) Compounds derived from n-aryl-acetamide, trpv1 antagonist, pharmaceutical composition that comprises them, useful in the treatment of pain.
ECSP088676A (en) PIRAZOLQUINOLONAS AS POWERFUL PARP INHIBITORS
BRPI0508254A (en) methods and compositions for treating or preventing psychiatric disorders with cox-2 inhibitors alone and in combination with antidepressant agents
BRPI0718469A2 (en) USE OF AN INTERLEUCIN 1 ANTAGONIST (IL-1), METHOD FOR TREATING, INHIBITING OR IMPROVING PSEUDOGOTA, USE OF ONE OR MORE THERAPEUTIC AGENTS, AND, PRODUCT.
BRPI0517438A (en) compound, method for treating the condition associated with muscarinic m4 receptor activity, compound use, and, pharmaceutical composition
BRPI0512705A (en) compound, its preparation process and method for the treatment and prophylaxis of diabetes, obesity, eating disorders, dilipidemia, hypertension, and type ii diabetes
BRPI0506970A (en) alpha-aminoamide derivatives useful in treating lower urinary tract disorders
BRPI0411095A (en) imidazole derivatives
WO2004052858A3 (en) Inhibitors of monoamine uptake
MX2007006081A (en) 4-phenyl substituted tetrahydroisoquinolines and use thereof to block reuptake of norepinephrine, dopamine and serotonin.
ATE421518T1 (en) DIHYDROQUINAZOLINONES AS 5HT MODULATORS
EA200701676A1 (en) DERIVATIVES OF DIHYDROIMIDAZETHIAZOLE

Legal Events

Date Code Title Description
B08F Application fees: dismissal - article 86 of industrial property law

Free format text: REFERENTE A 6A E 7A ANUIDADE(S)

B08K Lapse as no evidence of payment of the annual fee has been furnished to inpi (acc. art. 87)

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2129 DE 25/10/2011.